sNote: NCSI’s GATE™ atrioventricular valved stent, delivery catheter and related accessories are currently not available for sale or investigational use. NCSI plans to initiate clinical investigations pending completion of preclinical testing and authorizations from respective regulatory agencies.

NaviGate Cardiac Structures, Inc.
  • Home
  • About
  • Technology
  • Tricuspid Regurgitation
  • News & Events
  • Contact
Select Page

Euro PCR – Palais des Congrès – Paris, France

Date:
Location: Paris, France

2019 in Palais des Congrès – Paris, France

Recent Posts

  • iVascular SLU, Barcelona Invests in NaviGate Cardiac Structures, Inc.
  • Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada.
  • NaviGate Cardiac Structures, Inc., presents data of studies on the Gate™ valved stent for correction of Functional Tricuspid Regurgitation at Paris PCR2016.

Upcoming Events

  • Euro PCR – Palais des Congrès – Paris, FranceMay 1, 2019
  • PCR London Valves, European Association of Percutaneous Cardiovascular InterventionsSeptember 2, 2019
  • Transcatheter Cardiovascular Therapeutics (TCT), Cardiovascular Research FoundationSeptember 23, 2019

Topics

  • Announcement
  • Press Release
logo

Tricuspid Regurgitation, TR, FTR, Valve Replacement, Novel Solution, Unmet Clinical Need, Ignored Valve, Forgotten Valve

Browse

  • Home
  • About
  • Technology
  • Tricuspid Regurgitation
  • News & Events
  • Investors
  • Contact
Have Questions?

Do you have questions about the NaviGate™ System? Please let us know!

Send us an email

© 2019 NaviGate Cardiac Structures, Inc. - All Rights Reserved. Terms and Conditions | Privacy Policy | Website and Design by SDA Creative